Artificial intelligence is integrated across Sheba’s clinical and research environment—supporting earlier diagnosis, more precise treatment decisions, and improved patient outcomes. By analyzing large-scale clinical, imaging, and operational data, AI tools enhance the ability of physicians to identify patterns, assess risk, and tailor care in real time.

These capabilities are developed and tested within active clinical settings, enabling rapid translation from research to practice. AI supports a range of applications across the medical system, including imaging analysis, clinical decision support, patient monitoring, and operational efficiency.

As part of Sheba’s broader innovation ecosystem, artificial intelligence contributes to a more responsive, data-driven model of care—advancing how medicine is delivered in Israel and informing healthcare systems worldwide.

Sheba pioneers advanced robotic surgery systems that enable procedures with unprecedented precision. Combined with genomic profiling and real-time imaging, surgeons can tailor interventions to each patient’s unique anatomy and disease characteristics, reducing complications and accelerating recovery times across multiple surgical specialties.

Sheba leads the development of FDA-approved digital therapeutics and remote patient monitoring systems that extend world-class care beyond hospital walls. Our platforms now serve patients across six continents, using wearable sensors, AI analytics, and telemedicine to detect complications early and optimize treatment protocols in real time.

The Big Data Institute at Sheba analyzes over 2 million patient records to identify disease trends, predict outbreaks, and optimize treatment protocols. Machine learning models trained on this massive dataset have revealed unexpected connections between conditions, leading to novel therapeutic approaches and helping Israel prepare for pandemic responses with unprecedented efficiency.

Sheba Medical Center is advancing genomic research through large-scale studies in cancer genomics, hereditary diseases, and rare genetic disorders. Using next-generation sequencing, molecular diagnostics, and precision medicine approaches, Sheba researchers work to better understand how genetic variations influence disease development, treatment response, and long-term outcomes.

Through collaborations with leading international institutions, research networks, and biotechnology partners, Sheba is helping translate genomic discoveries into more personalized approaches to diagnosis and treatment.

Sheba Medical Center is one of Israel’s leading hubs for clinical research and innovation, contributing to approximately 25% of all clinical trials conducted in Israeli hospitals. Through partnerships with global pharmaceutical, biotechnology, and medical technology companies, Sheba helps accelerate the development of new therapies, medical devices, and AI-driven healthcare solutions.

The medical center conducts clinical trials across a wide range of specialties, including oncology, immunotherapy, neurology, cardiology, infectious disease, and digital health. By integrating research directly into clinical environments, Sheba gives eligible patients access to emerging therapies and innovative treatment approaches while contributing to global advances in medicine.